全球临床试验追踪与评论平台
自动追踪 NEJM、Lancet、JAMA、BMJ 等顶级期刊最新发表的 I、II、III 期临床试验, 提供方法学漏洞分析与高质量 Correspondence 评论生成
Eslicarbazepine acetate is an antiseizure medication that has shown potential antiepileptogenic effects in preclinical models of epilepsy. We aimed to investigate whether eslicarbazepine acetate could
It is widely believed that intensive task-specific training enhances neurological recovery in people with spinal cord injury (SCI) by exploiting activity-dependent spinal plasticity. We aimed to deter
Automated insulin delivery (AID) requiring manual premeal boluses are the standard of care for people with type 1 diabetes (T1D). We evaluated the safety and feasibility of the Automated Insulin Deliv
Newborns delivered by women with gestational diabetes mellitus (GDM) have accelerated intrauterine growth earlier than the current recommended screening period. We aimed to determine whether universal
Gene transfer is a promising therapeutic approach for Duchenne muscular dystrophy as the disease results from mutations in a single gene. Fordadistrogene movaparvovec is an investigational recombinant
Undertreated cancer symptoms are common among older adults, yet effective early identification and intervention remain limited. To determine whether lay health worker-led symptom assessment reduces ac
Pancreas divisum is implicated as an obstructive cause for acute pancreatitis. Observational data suggest endoscopic retrograde cholangiopancreatography (ERCP) with minor papillotomy reduces the risk
The effect of individualized high positive end-expiratory pressure (PEEP) and recruitment maneuvers, targeting a low driving pressure, on clinical outcomes in patients undergoing open abdominal surger
Left ventricular assist devices (LVADs), including the HeartMate 3 (HM3), have improved outcomes in patients with advanced heart failure. Use of vitamin K antagonists (VKA) is mandated to reduce the r
The J-START randomised controlled trial found that adjunctive ultrasonography was associated with significantly higher rates of breast cancer detection than mammography alone. This report aims to eval
Myotonic dystrophy type 1 is a rare, dominantly inherited, progressive, disabling, neuromuscular disease that leads to decreased life expectancy and has no approved therapies. The disease is caused by
Cystinosis is a multisystemic lysosomal storage disorder caused by pathogenic variants in CTNS, the gene encoding cystinosin, a lysosomal transmembrane cystine transporter. In patients with cystinosis
To evaluate whether vitamin D supplementation improves live birth rates in women with polycystic ovary syndrome undergoing in vitro fertilisation. Multicentre, double blind, placebo controlled, random
Liquid-stored platelets have a shelf-life of 5 to 7 days, limiting availability and resulting in wastage. To assess the effectiveness and safety of dimethyl sulfoxide-cryopreserved platelets, which ha
The management of patent ductus arteriosus (PDA) in preterm infants is controversial. To determine whether expectant management compared with active treatment of a protocol-defined PDA in preterm infa
Major depressive disorder (MDD) is a leading cause of disability worldwide, yet many patients have inadequate responses to current treatments. Dimethyltryptamine (DMT), a serotonergic psychedelic with
Antiretroviral therapy (ART) suppresses HIV but does not eliminate the latent viral reservoir, which persists in programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. Anti-PD-1 therapies hav
Even after endovascular thrombectomy, more than half of patients with acute large vessel occlusion stroke do not achieve favourable outcomes. This study aimed to assess the efficacy and safety of remo
In the VICTOR trial (NCT05093933), vericiguat was neutral for the primary composite endpoint of cardiovascular death or hospitalization for heart failure (HF). VICTOR was powered to independently asse
Antiplatelet treatment is recommended to start 24 h after intravenous thrombolysis due to concerns about haemorrhagic transformation. This study aimed to investigate the potential benefit of ea
The optimal therapy for patients with atherosclerotic renal artery stenosis (ARAS) remains unresolved. This study compared the efficacy of renal fractional flow reserve (FFR)-guided revascularization
Despite current antithrombotic treatments, the recurrence of ischaemic events remains high in patients with diabetes mellitus (DM) or aspirin resistance after acute coronary syndrome (ACS). Whether tw
Atrial fibrillation (AF) is associated with various lifestyle risk factors. Their presence negatively affects AF catheter ablation outcomes. This study evaluates the efficacy of a nurse-led, integrate
Recent trials have challenged the guideline recommendation of beta-blockers for post-myocardial infarction (MI) patients without reduced left ventricular ejection fraction (LVEF). Whether these recent
To assess treatment with camrelizumab (a programmed death 1 inhibitor) in addition to concurrent chemoradiotherapy and as a maintenance treatment in patients with high risk nasopharyngeal carcinoma. M
Low back pain (LBP) is influenced by interrelated physical, psychological, and social factors. However, most treatments focus on symptom reduction without addressing the underlying biopsychosocial nee
The most effective initial fraction of inspired oxygen (Fio2) for resuscitating preterm newborns is unknown. To compare outcomes of newborns born at 23 to 28 weeks' gestation resuscitated with initial
Neuroscientific, epidemiological, and electronic health record studies implicate herpes simplex virus (HSV) as potentially etiological for Alzheimer disease (AD). To compare the efficacy and adverse e
This study evaluated the incidence, determinants, and clinical impact of stent optimization after optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) for complex lesions
Global healthcare providers are exploring the use of large language models (LLMs) to provide medical advice to the public. LLMs now achieve nearly perfect scores on medical licensing exams, but this d
以下为 NEJM、Lancet、JAMA、BMJ 已发表的真实 Correspondence / Letter 案例, 展示平台生成的评论与顶级期刊发表标准高度一致——相同的批评视角、相同的方法学深度。
Statistical power concerns in REBOOT trial: despite reaching planned sample size, the confidence interval (HR 1.04; 95% CI 0.89–1.22) does not exclude a clinically meaningful harm or benefit, raising concerns about the robustness of the null conclusion.
Open-label design in IVF trial allowed clinicians to transfer significantly more double cleavage-stage embryos in the fresh arm (58.8% vs 49.6%), artificially inflating the live birth rate difference (40.1% vs 31.5%). Performance bias from unblinded allocation undermines causal inference.
Underpowered single-centre trial with late treatment initiation (median 13 days post-onset). Concurrent uncontrolled glucocorticoid use (33% of patients) confounded viral load outcomes. Secondary outcomes suggested potential mortality benefit (19% vs 25%) that the trial was insufficiently powered to confirm.
Methodological critique of passive surveillance data: official death counts underestimate true mortality by excluding indirect deaths from infrastructure collapse. Authors estimate true excess mortality may be 4× the reported figure, highlighting systematic undercounting bias in conflict-zone epidemiology.
High-scoring allocation concealment and double-blinding are independently associated with smaller treatment effect estimates (OR 0.87; 95% CI 0.79–0.96). Trials with inadequate concealment overestimate treatment effects by 13–41%, a systematic bias that inflates apparent efficacy across therapeutic areas.
Authors defend methodological rigour of a 154-RCT meta-analysis (112,515 participants) against critique of heterogeneity and subgroup validity. Exchange illustrates standard post-publication peer review process: challenging I² thresholds, subgroup pre-specification, and sensitivity analysis robustness.
自动提取试验设计、统计指标(HR/CI/P值)、关键结果等结构化信息
识别分配隐藏、盲法缺陷、统计功效不足等方法学漏洞,按风险等级分类
自动生成500词结构化英文 Correspondence 评论,可直接投稿顶级期刊
按疾病领域、试验阶段、期刊自定义订阅,及时获取最新试验动态